Thank you
Thank you for your interest, you may now access the content below.
Highlights from ESMO recommendations outline use of next-generation sequencing in metastatic cancer patients
Nicola Normanno
INT-Fondazione Pascale, Department of Experimental Oncology, Naples
Download presentation Watch symposium
Revolutionising the future of precision oncology research with Oncomine Solutions
Andy Felton
Vice President Product Management, Thermo Fisher Scientific
Download presentation Watch symposium
A European inter laboratory research evaluation of Oncomine Precision Assay on Ion Torrent Genexus System
Michael Hummel
Pathology Institute Berlin
Download presentation Watch symposium
Amplicon based NGS approach for gene fusions analysis from tissue to liquid biopsy
Umberto Malapelle
Chief Supervisor Predictive Molecular Pathology Laboratory, Department of Public Health, University Federico II of Naples
Download presentation Watch symposium
It's NGS, as fast and easy as IHC or PCR
The Oncomine Precision Assay on the Ion Torrent Genexus System features a complete next-generation sequencing (NGS) testing workflow. Now every lab can go from specimen to report in a single day, providing a comprehensive genomic profile at a speed never possible before. This allows you to deliver NGS results at the same time as other single-gene methods, such as immunohistochemistry (IHC) and PDL1 biomarker test. The hands-off, set-up-and-go workflow makes NGS accessible, even if your lab is new to the technology.
For Research Use Only. Not For Use In Diagnostic Procedures.
